Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase NA 1Phase 2 1

Status

Completed 10Unknown 7Recruiting 6Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Myeloid 7Lymphoid 1Dermatologic 1

Conditions

Breast Neoplasms 1476Neoplasms 999Colorectal Neoplasms 830Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 683Stomach Neoplasms 647Lung Neoplasms 584Prostatic Neoplasms 543Pancreatic Neoplasms 456Rectal Neoplasms 338Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 292Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 278Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 241Multiple Myeloma 232Brain Neoplasms 204Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 193Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 141

Interventions

midostaurin 1Phlebotomy 1Hydroxychloroquine 1Cladribine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × OTHER × Mastocytosis × Clear all
NCT06210698 2024-01-18

Angioedema Biomarker Research Study

Foundation For Rare Disease Research

Unknown
600 enrolled
Myeloid

Angioedema, Mastocytosis, Urticaria, Mastocytosis, Systemic, Angioedemas, Hereditary

NCT05923372 2023-07-12

DALY-MAST

University Hospital, Toulouse

Unknown
160 enrolled
Myeloid

Mastocytosis, Mastocytosis, Systemic

NCT05084872 2021-10-20

HCQMa

University Hospital, Toulouse

Phase 2/3 Unknown
30 enrolled
Myeloid

Mastocytosis

NCT04615663 2020-11-04

MCD&BuDi

University Hospital, Toulouse

Unknown
200 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT03340155 2017-11-13

BioUV2017

Medical University of Graz

Phase NA Unknown
240 enrolled
DermatologicLymphoidMyeloid

Eczema, Graft vs Host Disease, Lichen Planus, Lymphoproliferative Disorders, Mastocytosis, Prurigo, Pruritus, Psoriasis, Vitiligo, Lymphoma, T-Cell, Cutaneous

NCT01602939 2016-08-29

Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis

Hospital Virgen de la Salud

Phase 2/3 Unknown
10 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

NCT01920204 2015-01-19

Midostaurin in Indolent Systemic Mastocytosis

University Medical Center Groningen

Phase 2 Unknown
20 enrolled
Myeloid

Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡